SmadminX is a biotech start up developing VHH (nano-bodies) therapeutics to prevent metastatic spread in selected gastroenterological patient populations
About
SmadMinX is a biotech startup company, which was founded by prof. Dr Sheila Krishnadath, who has a long track record on cancer research. The mission of the spin-off company is to improve the ooutcomes of cancer patients. Our vision is that this can be achieved by inhibiting the pathways that lead to the formation of metastasis in patients with highly aggressive cancers. Hereto SmadMinX has developed higly specific low molecular weight antibodies which need to be further developed to the clinic.
